Why the study?
Does an internal pacemaker control thioridazine-induced ventricular tachycardia in a patient failing usual therapeutic measures?
Does an internal pacemaker control thioridazine-induced ventricular tachycardia in a patient failing usual therapeutic measures?
This early case report demonstrates the successful use of an artificial pacemaker to control drug-induced (thioridazine) ventricular tachycardia refractory to standard therapies.
Answers are grounded in this paper and cite their sources.
May support pacing in refractory thioridazine-induced VT; leaves open generalizability and need for prospective data.
Brief Communication1 November 1966Thioridazine (Mellaril®)-induced Ventricular Tachycardia Controlled with an Artificial PacemakerFRED W. SCHOONMAKER, M.D., ROBERT T. OSTEEN, A.B., JOSEPH C. GREENFIELD JR., M.D.FRED W. SCHOONMAKER, M.D., ROBERT T. OSTEEN, A.B., JOSEPH C. GREENFIELD JR., M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-65-5-1076 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptSince its introduction in 1959 as a psychotropic agent, thioridazine hydrochloride (Mellaril®) has shown a wide margin of therapeutic safety (1). Although it has antiarrhythmic properties (2), ventricular arrhythmias have occurred rarely during therapy with large doses (3, 4). In this paper, we report [1] ventricular tachycardia secondary to moderate amounts of thioridazine and [2] the successful treatment of this arrhythmia with an internal pacemaker after failure of the usual therapeutic measures.CASE REPORTPatient E. E. S., a 50-year-old Negro man, was admitted to the Durham Veterans Administration Hospital on October 30, 1965, for evaluation of schizophrenia. He had...References1. DIERKS M: A comparison of two phenothiazines in the treatment of schizophrenics. Amer. J. Psychiat. 119: 775, 1963. CrossrefMedlineGoogle Scholar2. MADANPENDSE BRVK: Antiarrhythmic activity of thioridazine hydrochloride (Mellaril). Amer. J. Cardiol. 11: 78, 1963. CrossrefGoogle Scholar3. DESAUTELSFILTEAUST.-JEAN SCA: Ventricular tachycardia associated with administration of thioridazine hydrochloride (Mellaril): report of a case with a favourable outcome. Canad. Med. Ass. J. 90: 1030, 1964. MedlineGoogle Scholar4. KELLYFAYLAVERTY HGJESG: Thioridazine hyrochloride (Mellaril): its effect on the electrocardiogram and a report of two fatalities with electrocardiographic abnormalities. Canad. Med. Ass. J. 89: 546, 1963. MedlineGoogle Scholar5. BANST.-JEAN TAA: The effect of phenothiozines on the electrocardiogram. Canad. Med. Ass. J. 91: 537, 1964. MedlineGoogle Scholar6. SOWTONLEATHAMCARSON EAP: The suppression of arrhythmias by artificial pacemaking. Lancet 2: 1098, 1964. CrossrefMedlineGoogle Scholar7. HEIMANHELWIG DFJ: Suppression of ventricular arrythmias by transvenous intracardiac pacing. JAMA 195: 172, 1966. CrossrefGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Durham, North CarolinaFrom the Department of Medicine, Durham Veterans Administration Hospital, and the Department of Medicine, the Duke University Medical Center, Durham, N. C.Dr. Greenfield is the recipient of a Career Development Award, supported by grant 1-K3-HE-28,112, the U. S. Public Health Service, Washington, D. C.Requests for reprints should be addressed to Fred W. Schoonmaker, M.D., Chief, Cardiovascular-Renal Section, Department of Medicine, Veterans Administration Hospital, Durham, N. C. 27705. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByRevisiting atrial pacing in the long QT genotype eraThe Jervell and Lange-Nielsen syndrome; atrial pacing combined with ß-blocker therapy, a favorable approach in young high-risk patients with long QT syndrome?Ventricular Tachycardia due to Long QT Syndrome Associated to Non-Cardiac Pharmacological AgentsA Tale of 2 DiseasesPro-Arrhythmic Effects of Noncardiac MedicationsInhibitors of hERG Channel TraffickinghERG K + Channels: Structure, Function, and Clinical SignificanceCardiorespiratory depression and haemolysis due to thioridazine overdose in the ratHuman ether-a-go-go related gene (hERG) K+ channels: Function and dysfunctionCardiac Repolarisation and Drug RegulationThe Difference Between the Formal and the Functional Dose: The Case of the Patient on Thioridazine and FluvoxamineTorsade de pointes induced by psychotropic drugs and the prevalence of its risk factorsPharmacokinetic Factors in the Adverse Cardiovascular Effects of Antipsychotic DrugsTorsade de Pointes Due to Noncardiac DrugsClinical Relevance and Management of Drug-Related QT Interval ProlongationLong QT syndrome caused by noncardiac drugsNear fatal case of self-poisoning with thioridazineConcentration-related pharmacodynamic effects of thioridazine and its metabolites in humansThe Association Between Intravenous Haloperidol and Torsades de PointesCardiac Consultation In Patients With Neuropsychiatry ProblemsProarrhythmia: Definition, risk factors, causes, treatment, and controversiesPhenothiazine-Associated Supraventricular TachycardiaA survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in FinlandVentricular Tachyarrhythmias Related to Early Afterdepolarizations and Triggered Firing: Relationship to QT Interval Prolongation and Potential Therapeutic Role for Calcium Channel Blocking AgentsThe long QT syndromes: A critical review, new clinical observations and a unifying hypothesisTorsades de pointes associated with drugs and toxins: Recognition and managementIatrogenic torsade de pointes induced by thioridazineVentricular Tachycardia: Historical PerspectiveCalcium channel blockers that prolong the QT intervalHerzrhythmusstörungenVentricular Tachyarrhythmias in the Long QT SyndromesTORSADE DE POINTES: DEFINITIONS, CAUSATIVE FACTORS, AND THERAPY: EXPERIENCE WITH SIXTEEN PATIENTSOverdrive Pacing for Ventricular Tachyarrhythmias: A ReassessmentPETER R. KOWEY, M.D., TOBY R. ENGEL, M.D.Torsade de pointes: The long-short initiating sequence and other clinical features: observations in 32 patientsThe QT interval historically treatedPolymorphous ventricular tachycardia associated with normal and long Q-T intervalsQ-T prolongation and polymorphous ("torsade de pointes") ventricular arrhythmias associated with organophosphorus insecticide poisoningEtiology, warning signs and therapy of torsade de pointes. A study of 10 patients.Management of recurrent ventricular tachyarrhythmias associated with Q-T prolongationTemporary cardiac pacing: Applications and techniques in the treatment of cardiac arrhythmiasClinical Electrophysiology of Ventricular TachycardiaTorsade De PointesVentricular pacing in atypical ventricular tachycardia"Les Torsades de Pointes": An Unusual Ventricular ArrhythmiaWARREN M. SMITH, M.D., JOHN J. GALLAGHER, M.D.Prenylamine-induced ventricular tachycardia and syncope controlled by ventricular pacing.Current status of pacemaker therapy of arrhythmiasFATAL THIORIDAZINE CARDIOTOXICITYStudy of Thioridazine Cardiotoxic Effects by Means of His Bundle Activity Recording***Antiarrhythmic action of minor and major tranquilizersPermanent Programmable Pacemakers in the Management of Recurrent Tachycardias*Comparison of the electrophysiological effects of two neuroleptics, melperone and thioridazine, on isolated rat atriaSuccessful treatment by overdrive pacing of recurrent quinidine syncope due to ventricular tachycardiaAdverse reactions to quinidine in hospitalized patients: Findings based on data from the boston collaborative drug surveillance programVentricular Fibrillo-Flutter ("Torsade De Pointe"): an Established Electrocardiographic and Clinical EntityElectrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugsTorsade De Pointes, an atypical ventricular tachycardia.Ventricular tachycardia: a new iatrogenic possibilityInteractions of CNS Drugs: Psychotherapeutic Agents—The Antipsychotic DrugsTreatment of Tachyarrhythmias and Bradyarrhythmias by Cardiac Sympathectomy and Permanent Ventricular PacingCardiac Function in Patients Treated with Phenothiazines. Comparison with QuinidineTreatment of arrhythmias by intracardiac electrical stimulationElectric control of the heartElectric control of the heartRelationship between heart rate and ventricular ectopic rhythm in acute myocardial infarctionElectrical Cardiac Pacing in Patients Without Heart BlockRecent advances in the treatment of ectopic tachycardias by electrical pacingRECURRENT VENTRICULAR TACHYARRHYTHMIAS IN A PATIENT WITH A PROLONGED Q‐T INTERVALThe use of ventricular pacing for suppression of ectopic ventricular activitySuppression of refractory recurrent ventricular tachycardia by transvenous rapid cardiac pacing and antiarrhythmic drugsCardiac Pacing in the Prevention and Treatment of TachyarrhythmiasLong-Term Pervenous Atrial PacingCardiotoxic effects of Mellaril: Conduction disturbances and supraventricular arrhythmiasThe Stokes-Adams syndromeArtificial Atrial and Ventricular Pacing in the Treatment of ArrhythmiasDOUGLAS P. ZIPES, M.D., ANDREW G. WALLACE, M.D., WILL C. SEALY, M.D., WALTER L. FLOYD, M.D., F.A.C.P.Coronary and precoronary careProtection of implanted pacemakers from excessive electrical energy of D.C. shockTransvenous ventricular pacing in the treatment of paroxysmal atrial tachyarrhythmias alternating with sinus bradycardia and standstillElectrocardiographic abnormalities induced by thioridazine (Mellaril)Rapid intracardiac pacing for treatment of recurrent ventricular tachyarrhythmias in the absence of heart blockTreatment of Ventricular Arrhythmia by Permanent Atrial Pacemaker and Cardiac SympathectomyDOUGLAS P. ZIPES, M.D., BARRY FESTOFF, M.D., STEPHEN F. SCHAAL, M.D., CLYDE COX, M.D., WILL C. SEALY, M.D., ANDREW G. WALLACE, M.D.Paroxysmal Ventricular Fibrillation in Two Patients with HypomagnesemiaRefractory Paroxysmal Ventricular TachycardiaDOUGLAS P. ZIPES, M.D., EDWARD S. ORGAIN, M.D., F.A.C.P.The Control of Ventricular Tachyarrhythmias by Internal Cardiac PacingJOSEPH C. GREENFIELD JR., M.D., EDWARD S. ORGAIN, M.D.Recurrent Ventricular Tachycardia and Fibrillation Treated with a Combination of Beta-Adrenergic Blockade and Electrical PacingLAWRENCE S. COHEN, M.D., ROBERT A. BUCCINO, M.D., ANDREW G. MORROW, M.D., EUGENE BRAUNWALD, M.D., F.A.C.P. 1 November 1966Volume 65, Issue 5Page: 1076-1078KeywordsArrhythmiaHospital medicineMedical servicesPacemakersPrevention, policy, and public healthSchizophreniaTachycardiaVentricular tachycardia Issue Published: 1 November 1966 PDF DownloadLoading ...
No takes yet. Share an insight, caveat, or question.
Fred W. Schoonmaker (1966) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: